-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Otw67lYihRQPiaTik2MIHWseMdLnvMFdGOvgyXTWEXJfB/V6RfCVo0ZWwN2MoC+/ +0n9MCCOXxsox5mkZk5Yww== 0001017062-98-002554.txt : 19981228 0001017062-98-002554.hdr.sgml : 19981228 ACCESSION NUMBER: 0001017062-98-002554 CONFORMED SUBMISSION TYPE: 424B3 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19981223 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CORTEX PHARMACEUTICALS INC/DE/ CENTRAL INDEX KEY: 0000849636 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330303583 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 424B3 SEC ACT: SEC FILE NUMBER: 333-29493 FILM NUMBER: 98774760 BUSINESS ADDRESS: STREET 1: 15241 BARRANCA PKWY CITY: IRVINE STATE: CA ZIP: 92718 BUSINESS PHONE: 7147273157 MAIL ADDRESS: STREET 2: 15241 BARRANCA PARKWAY CITY: IRVINE STATE: CA ZIP: 92718 424B3 1 SUPPLEMENT #2 TO PROSPECTUS DATED 12-11-1998 RULE 424(b)(3) REGISTRATION NO. 333-29493 SUPPLEMENT DATED DECEMBER 23, 1998 SUPPLEMENT NO. 2 TO PROSPECTUS DATED DECEMBER 11, 1998 OF CORTEX PHARMACEUTICALS, INC. Increase in Number of Shares of Common Stock Issuable Upon Conversion of Series - ------------------------------------------------------------------------------- A Preferred Stock - ----------------- As of December 23, 1998 the effective conversion price for the Company's Series A Preferred Stock has decreased from $0.5379 per share to $0.3481 per share due to a reduction in the market price of the Company's common stock. Since December 11, 1998, the Company has issued 329,064 of the 525,556 shares of common stock included in the prospectus as issuable upon conversion of the Series A Preferred Stock. As of December 23, 1998, at an effective conversion price of $0.3481 per share, the number of shares of common stock issuable upon conversion of the outstanding Series A Preferred Stock is 406,927. The prospectus cover page and the outside back cover page of the Company's prospectus dated December 11, 1998 and the table entitled "Selling Stockholders" are hereby supplemented to reflect the foregoing information. -----END PRIVACY-ENHANCED MESSAGE-----